Atlas Trials

Percutaneous Sclerotherapy of Symptomatic Liver Hemangioma With Bleomycin

Clinical trial NCT03649113 · COMPLETED

Trial details

NCT number
NCT03649113
Sponsor
Tehran University of Medical Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemangioma Liver
Start date
2018-09-01
Primary completion
2019-09-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.